Management of long-term colorectal cancer survivors in Korea

Hee Taik Kang, Hyun Jung Bahk, Jae Yong Shim, Nam Kyu Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Colorectal cancer (CRC) is the third most common cancer in Korea. Its average growth rate has been 3.7% annually from 1999 to 2013. The 5-year relative survival rate is 75.6%. The number of CRC survivors is expected to increase steadily because of its high incidence and survival rate. Because CRC survivors are at risk for recurrence, metachronous cancer, and other cancers, they should be checked regularly. Recommended surveillance includes history-taking and physical examination, colonoscopy, carcinoembryonic antigen testing, and computed tomography. Routine complete blood counts, liver function test, and positron emission tomography are not recommended. CRC survival, which is associated with Lynch syndrome and familial adenomatous polyposis, is also related to a higher risk of other cancers such as gastrointestinal and gynecologic cancers. Additional surveillance should be taken. CRC survivors could complain of general health problems such as cancer-related fatigue and psychosocial/cognitive dysfunction, in addition to treatment-related problems including bowel/urologic/sexual dysfunction, peripheral neuropathy, and ostomy care. They are also at greater risk of cardiovascular diseases. The primary care physician should counsel CRC survivors about their health problems and make an effort to address these concerns. Primary care physicians should try to communicate with CRC survivors and all specialists for clinical follow-up care.

Original languageEnglish
Pages (from-to)276-286
Number of pages11
JournalJournal of the Korean Medical Association
Volume59
Issue number4
DOIs
Publication statusPublished - 2016 Apr

Fingerprint

Korea
Colorectal Neoplasms
Primary Care Physicians
Neoplasms
Ostomy
Hereditary Nonpolyposis Colorectal Neoplasms
Aftercare
Adenomatous Polyposis Coli
Gastrointestinal Neoplasms
Blood Cell Count
Liver Function Tests
Carcinoembryonic Antigen
Health
Peripheral Nervous System Diseases
Colonoscopy
Positron-Emission Tomography
Physical Examination
Fatigue
Cardiovascular Diseases
History

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kang, Hee Taik ; Bahk, Hyun Jung ; Shim, Jae Yong ; Kim, Nam Kyu. / Management of long-term colorectal cancer survivors in Korea. In: Journal of the Korean Medical Association. 2016 ; Vol. 59, No. 4. pp. 276-286.
@article{a8a6a6f64e4f4f158443a6db50b6b215,
title = "Management of long-term colorectal cancer survivors in Korea",
abstract = "Colorectal cancer (CRC) is the third most common cancer in Korea. Its average growth rate has been 3.7{\%} annually from 1999 to 2013. The 5-year relative survival rate is 75.6{\%}. The number of CRC survivors is expected to increase steadily because of its high incidence and survival rate. Because CRC survivors are at risk for recurrence, metachronous cancer, and other cancers, they should be checked regularly. Recommended surveillance includes history-taking and physical examination, colonoscopy, carcinoembryonic antigen testing, and computed tomography. Routine complete blood counts, liver function test, and positron emission tomography are not recommended. CRC survival, which is associated with Lynch syndrome and familial adenomatous polyposis, is also related to a higher risk of other cancers such as gastrointestinal and gynecologic cancers. Additional surveillance should be taken. CRC survivors could complain of general health problems such as cancer-related fatigue and psychosocial/cognitive dysfunction, in addition to treatment-related problems including bowel/urologic/sexual dysfunction, peripheral neuropathy, and ostomy care. They are also at greater risk of cardiovascular diseases. The primary care physician should counsel CRC survivors about their health problems and make an effort to address these concerns. Primary care physicians should try to communicate with CRC survivors and all specialists for clinical follow-up care.",
author = "Kang, {Hee Taik} and Bahk, {Hyun Jung} and Shim, {Jae Yong} and Kim, {Nam Kyu}",
year = "2016",
month = "4",
doi = "10.5124/jkma.2016.59.4.276",
language = "English",
volume = "59",
pages = "276--286",
journal = "Journal of the Korean Medical Association",
issn = "1975-8456",
publisher = "Korean Medical Association",
number = "4",

}

Management of long-term colorectal cancer survivors in Korea. / Kang, Hee Taik; Bahk, Hyun Jung; Shim, Jae Yong; Kim, Nam Kyu.

In: Journal of the Korean Medical Association, Vol. 59, No. 4, 04.2016, p. 276-286.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Management of long-term colorectal cancer survivors in Korea

AU - Kang, Hee Taik

AU - Bahk, Hyun Jung

AU - Shim, Jae Yong

AU - Kim, Nam Kyu

PY - 2016/4

Y1 - 2016/4

N2 - Colorectal cancer (CRC) is the third most common cancer in Korea. Its average growth rate has been 3.7% annually from 1999 to 2013. The 5-year relative survival rate is 75.6%. The number of CRC survivors is expected to increase steadily because of its high incidence and survival rate. Because CRC survivors are at risk for recurrence, metachronous cancer, and other cancers, they should be checked regularly. Recommended surveillance includes history-taking and physical examination, colonoscopy, carcinoembryonic antigen testing, and computed tomography. Routine complete blood counts, liver function test, and positron emission tomography are not recommended. CRC survival, which is associated with Lynch syndrome and familial adenomatous polyposis, is also related to a higher risk of other cancers such as gastrointestinal and gynecologic cancers. Additional surveillance should be taken. CRC survivors could complain of general health problems such as cancer-related fatigue and psychosocial/cognitive dysfunction, in addition to treatment-related problems including bowel/urologic/sexual dysfunction, peripheral neuropathy, and ostomy care. They are also at greater risk of cardiovascular diseases. The primary care physician should counsel CRC survivors about their health problems and make an effort to address these concerns. Primary care physicians should try to communicate with CRC survivors and all specialists for clinical follow-up care.

AB - Colorectal cancer (CRC) is the third most common cancer in Korea. Its average growth rate has been 3.7% annually from 1999 to 2013. The 5-year relative survival rate is 75.6%. The number of CRC survivors is expected to increase steadily because of its high incidence and survival rate. Because CRC survivors are at risk for recurrence, metachronous cancer, and other cancers, they should be checked regularly. Recommended surveillance includes history-taking and physical examination, colonoscopy, carcinoembryonic antigen testing, and computed tomography. Routine complete blood counts, liver function test, and positron emission tomography are not recommended. CRC survival, which is associated with Lynch syndrome and familial adenomatous polyposis, is also related to a higher risk of other cancers such as gastrointestinal and gynecologic cancers. Additional surveillance should be taken. CRC survivors could complain of general health problems such as cancer-related fatigue and psychosocial/cognitive dysfunction, in addition to treatment-related problems including bowel/urologic/sexual dysfunction, peripheral neuropathy, and ostomy care. They are also at greater risk of cardiovascular diseases. The primary care physician should counsel CRC survivors about their health problems and make an effort to address these concerns. Primary care physicians should try to communicate with CRC survivors and all specialists for clinical follow-up care.

UR - http://www.scopus.com/inward/record.url?scp=84964702361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964702361&partnerID=8YFLogxK

U2 - 10.5124/jkma.2016.59.4.276

DO - 10.5124/jkma.2016.59.4.276

M3 - Article

AN - SCOPUS:84964702361

VL - 59

SP - 276

EP - 286

JO - Journal of the Korean Medical Association

JF - Journal of the Korean Medical Association

SN - 1975-8456

IS - 4

ER -